Publications 2022

Bramness JG, Hjellvik V, Stubhaug A, Skurtveit S (2022)
Possible opioid-saving effect of cannabis-based medicine using individual-based data from the Norwegian Prescription Database
Basic Clin. Pharmacol. Toxicol., 130 (1), 84-92
DOI 10.1111/bcpt.13660

Publications 2021

Andreas JB, Torvik FA, Ystrom E, Skurtveit S, Handal M, Martinez P, Laslett AM, Lund IO (2021)
Parental Risk Constellations and Future Alcohol Use Disorder (AUD) in Offspring: A Combined HUNT Survey and Health Registries Study
Psychol. Addict. Behav.
DOI 10.1037/adb0000681

Fadnes LT, Aas CF, Vold JH, Leiva RA, Ohldieck C, Chalabianloo F, Skurtveit S, Lygren OJ, Dalgard O, Vickerman P, Midgard H, Loberg EM, Johansson KA, INTRO-HCV Study Grp (2021)
Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)
PLos Med., 18 (6), e1003653
DOI 10.1371/journal.pmed.1003653

Fredheim OM, Skurtveit S, Sjogren P, Aljabri B, Hjellvik V (2021)
Prescriptions of analgesics during chronic cancer disease trajectories: A complete national cohort study
Pharmacoepidemiol. Drug Saf., 30 (11), 1504-1513
DOI 10.1002/pds.5329

Gabrhelik R, Mahic M, Lund IO, Bramness J, Selmer R, Skovlund E, Handal M, Skurtveit S (2021)
Cannabis Use during Pregnancy and Risk of Adverse Birth Outcomes: A Longitudinal Cohort Study
Eur. Addict. Res., 27 (2), 131-141
DOI 10.1159/000510821

Gabrhelik R, Skurtveit S, Nechanska B, Handal M, Mahic M, Mravcik V (2021)
Prenatal Methamphetamine Exposure and Adverse Neonatal Outcomes: A Nationwide Cohort Study
Eur. Addict. Res., 27 (2), 97-106
DOI 10.1159/000509048

Hamina A, Handal M, Fredheim O, Clausen T, Chen LC, Skurtveit S (2021)
Filled prescriptions for opioids among children and adolescents - A nationwide study from 2010 to 2018
Acta Anaesthesiol. Scand., 65 (10), 1475-1483
DOI 10.1111/aas.13968

Holdo I, Bramness JG, Handal M, Hansen BH, Hjellvik V, Skurtveit S (2021)
Association Between Prescribed Hypnotics in Infants and Toddlers and Later ADHD: A Large Cohort Study from Norway
Child Psychiat. Hum. Dev., 52 (4), 533-543
DOI 10.1007/s10578-020-01039-9

Skjaervo I, Clausen T, Skurtveit S, Bukten A (2021)
Desistance from crime following substance use treatment: the role of treatment retention, social network and self-control
BMC Psychiatry, 21 (1), 563
DOI 10.1186/s12888-021-03518-2

Torp HA, Skurtveit S, Skaga NO, Gustavsen I, Gran JM, Rosseland LA (2021)
Pre-injury dispensing of psychoactive prescription drugs in a ten years trauma population: a retrospective registry analysis
Scand. J. Trauma Resusc. Emerg. Med., 29 (1), 125
DOI 10.1186/s13049-021-00939-6

Tronnes JN, Lupattelli A, Handal M, Skurtveit S, Ystrom E, Nordeng H (2021)
Association of Timing and Duration of Prenatal Analgesic Opioid Exposure With Attention-Deficit/Hyperactivity Disorder in Children
JAMA Netw. Open, 4 (9), e2124324
DOI 10.1001/jamanetworkopen.2021.24324

Wesselhoeft R, Rasmussen L, Jensen PB, Jennum PJ, Skurtveit S, Hartz I, Reutfors J, Damkier P, Bliddal M, Pottegard A (2021)
Use of hypnotic drugs among children, adolescents, and young adults in Scandinavia
Acta Psychiatr. Scand., 144 (2), 100-112
DOI 10.1111/acps.13329

Aas CF, Vold JH, Gjestad R, Skurtveit S, Lim AG, Varden Gjerde K, Loberg EM, Johansson KA, Fadnes LT, INTRO-HCV Study Grp (2021)
Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway
Subst/ Abus. Treatment Prev. Pol., 16 (1), 20
DOI 10.1186/s13011-021-00354-1

Publications 2020

Ask H, Handal M, Hauge LJ, Reichborn-Kjennerud T, Skurtveit S (2020)
Incidence of diagnosed pediatric anxiety disorders and use of prescription drugs: a nation-wide registry study
Eur. Child Adolesc. Psych., 29 (8), 1063-1073
DOI 10.1007/s00787-019-01419-0

Fredheim OM, Skurtveit S, Loge JH, Sjogren P, Handal M, Hjellvik V (2020)
Prescription of analgesics to long-term survivors of cancer in early adulthood, adolescence, and childhood in Norway: a national cohort study
Pain, 161 (5), 1083-1091
DOI 10.1097/j.pain.0000000000001800

Handal M, Skurtveit S, Mahic M, Ohman I, Wikner BN, Tjagvad C, Kieler H, Halmesmaki E, Lund IO (2020)
Opioid maintenance treatment of pregnant women in the Scandinavian countries
Nord. Stud. Alcohol Drugs, 37 (3), 1455072520914114-312
DOI 10.1177/1455072520914114

Hoff M, Skovlund E, Skurtveit S, Meyer HE, Langhammer A, Sogaard AJ, Syversen U, Forsmo S, Abrahamsen B, Schei B (2020)
Proton pump inhibitors and fracture risk. The HUNT study, Norway
Osteoporosis Int., 31 (1), 109-118
DOI 10.1007/s00198-019-05206-0

Huitfeldt A, Sundbakk LM, Skurtveit S, Handal M, Nordeng H (2020)
Associations of Maternal Use of Benzodiazepines or Benzodiazepine-like Hypnotics During Pregnancy With Immediate Pregnancy Outcomes in Norway
JAMA Netw. Open, 3 (6), e205860
DOI 10.1001/jamanetworkopen.2020.5860

Kiselev Y, Handal M, Hjellvik V, Reichborn-Kjennerud T, Stoltenberg C, Suren P, Havdahl A, Skurtveit S (2020)
Nationwide Study of Neuropsychiatric Comorbidity and Medicines Use in Children With Autism Spectrum Disorder in Norway
Front. Psychiatry, 11, 596032
DOI 10.3389/fpsyt.2020.596032

Mahic M, Hernandez-Diaz S, Wood M, Kieler H, Odsbu I, Norgaard M, Ozturk B, Bateman BT, Hjellvik V, Skurtveit S, Handal M (2020)
In utero opioid exposure and risk of infections in childhood: A multinational Nordic cohort study
Pharmacoepidemiol. Drug Saf., 29 (12), 1596-1604
DOI 10.1002/pds.5088

Mravcik V, Nechanska B, Gabrhelik R, Handal M, Mahic M, Skurtveit S (2020)
Socioeconomic characteristics of women with substance use disorder during pregnancy and neonatal outcomes in their newborns: A national registry study from the Czech Republic
Drug Alcohol Depend., 209, 107933
DOI 10.1016/j.drugalcdep.2020.107933

Munch EL, Skurtveit S, Handal M, Skovlund E (2020)
Pre conception use of cannabis and cocaine among men with pregnant partners
Nord. Stud. Alcohol Drugs, 37 (1), 1455072519879564-53
DOI 10.1177/1455072519879564

Skovlund E, Selmer R, Skurtveit S, Brandlistuen RE, Handal M (2020)
In utero exposure to analgesic opioids and language development in 5-year old children
Pharmacoepidemiol. Drug Saf., 29 (6), 736-744
DOI 10.1002/pds.5009

Skurtveit S, Hjellvik V, Sakshaug S, Borchgrevink PC, Larsen BM, Clausen T, Skovlund E, Heggen EE, Handal M (2020)
Prescribing opioids on blue prescription for long term pain
Tidsskr. Nor. Laegeforen., 140 (15), 1552-1556

Vold JH, Gjestad R, Aas CF, Chalabianloo F, Skurtveit S, Loberg EM, Johansson KA, Fadnes LT, INTRO HCV Study Grp (2020)
Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016-2020
Subst/ Abus. Treatment Prev. Pol., 15 (1), 93
DOI 10.1186/s13011-020-00334-x

Vold JH, Skurtveit S, Aas C, Chalabianloo F, Kloster PS, Johansson KA, Fadnes LT (2020)
Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017
BMC Health Serv. Res., 20 (1), 352
DOI 10.1186/s12913-020-05195-5

Vold JH, Skurtveit S, Aas C, Johansson KA, Fadnes LT (2020)
Too much or too little opioids to patients receiving opioid agonist therapy in Norway (2013-2017): a prospective cohort study
BMC Health Serv. Res., 20 (1), 668
DOI 10.1186/s12913-020-05504-y

Vold JH, Aas C, Skurtveit S, Odsbu I, Chalabianloo F, Halmoy A, Johansson KA, Fadnes LT (2020)
Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; a national prospective cohort study in Norway from 2015 to 2017
BMC Psychiatry, 20 (1), 119
DOI 10.1186/s12888-020-02526-y

Vold JH, Aas C, Skurtveit S, Odsbu I, Chalabianloo F, Reutfors J, Halmoy A, Johansson KA, Fadnes LT (2020)
Potentially addictive drugs dispensing to patients receiving opioid agonist therapy: a register-based prospective cohort study in Norway and Sweden from 2015 to 2017
BMJ Open, 10 (8), e036860
DOI 10.1136/bmjopen-2020-036860

Welle-Strand GK, Skurtveit S, Abel KF, Chalabianloo F, Sarfi M (2020)
Living a normal life? Follow-up study of women who had been in opioid maintenance treatment during pregnancy
J. Subst. Abus. Treat., 113, 108004
DOI 10.1016/j.jsat.2020.108004

Welle-Strand GK, Skurtveit S, Clausen T, Sundal C, Gjersing L (2020)
COVID-19 survey among people who use drugs in three cities in Norway
Drug Alcohol Depend., 217, 108302
DOI 10.1016/j.drugalcdep.2020.108302

Aas CF, Vold JH, Skurtveit S, Lim AG, Ruths S, Islam K, Askildsen JE, Loberg EM, Fadnes LT, Johansson KA, INTRO HCV Study Grp (2020)
Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway
Subst/ Abus. Treatment Prev. Pol., 15 (1), 68
DOI 10.1186/s13011-020-00309-y

Aas CF, Vold JH, Skurtveit S, Odsbu I, Chalabianloo F, Lim AG, Johansson KA, Fadnes LT (2020)
Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017
Subst/ Abus. Treatment Prev. Pol., 15 (1), 44
DOI 10.1186/s13011-020-00286-2

Aas CF, Vold JH, Skurtveit S, Odsbu I, Chalabianloo F, Okland JM, Leiva RAM, Vickerman P, Johansson KA, Fadnes LT (2020)
On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017
BMJ Open, 10 (8), e036355
DOI 10.1136/bmjopen-2019-036355

Publications 2019

Birke H, Ekholm O, Sjogren P, Fredheim O, Clausen T, Skurtveit S (2019)
Tramadol use in Norway: A register-based population study
Pharmacoepidemiol. Drug Saf., 28 (1), 54-61
DOI 10.1002/pds.4626

Evandt J, Skurtveit S, Oftedal B, Krog NH, Nafstad P, Skovlund E, Schwarze PE, Aasvang GM (2019)
Agreement between self-reported and registry-based use of sleep medications and tranquilizers
Pharmacoepidemiol. Drug Saf., 28 (10), 1336-1343
DOI 10.1002/pds.4854

Fadnes LT, Aas CF, Vold JH, Ohldieck C, Leiva RA, Chalabianloo F, Skurtveit S, Lygren OJ, Dalgard O, Vickerman P, Midgard H, Loberg EM, Johansson KA, Buljovcic VB, Daltveit JT, Alpers SE, Eriksen TF, Gundersen P, Hille V, Haberg KH, Carlsen SEL, Bonnier ML, Loras L, Nordbotn MH, Nygard C et al. (2019)
Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)
BMC Infect. Dis., 19 (1), 943
DOI 10.1186/s12879-019-4598-7

Fredheim OM, Skurtveit S, Handal M, Hjellvik V (2019)
A complete national cohort study of prescriptions of analgesics and benzodiazepines to cancer survivors in Norway 10 years after diagnosis
Pain, 160 (4), 852-859
DOI 10.1097/j.pain.0000000000001459

Handal M, Nechanska B, Skurtveit S, Lund IO, Gabrhelik R, Engeland A, Mravcik V (2019)
Prenatal exposure to opioid maintenance treatment and neonatal outcomes: Nationwide registry studies from the Czech Republic and Norway
Pharmacol. Res. Perspect., 7 (5), e00501
DOI 10.1002/prp2.501

Lund IO, Skurtveit S, Handal M, Bukten A, Torvik FA, Ystrom E, Andreas JB (2019)
Association of Constellations of Parental Risk With Children's Subsequent Anxiety and Depression Findings From a HUNT Survey and Health Registry Study
JAMA Pediatr., 173 (3), 251-259
DOI 10.1001/jamapediatrics.2018.4360

Lupattelli A, Chambers CD, Bandoli G, Handal M, Skurtveit S, Nordeng H (2019)
Association of Maternal Use of Benzodiazepines and Z-Hypnotics During Pregnancy With Motor and Communication Skills and Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers
JAMA Netw. Open, 2 (4), e191435
DOI 10.1001/jamanetworkopen.2019.1435

Muller AE, Clausen T, Sjogren P, Odsbu I, Skurtveit S (2019)
Prescribed opioid analgesic use developments in three Nordic countries, 2006-2017
Scand. J. Pain, 19 (2), 345-353
DOI 10.1515/sjpain-2018-0307

Muller AE, Skurtveit S, Clausen T (2019)
Performance of the WHOQOL-BREF among Norwegian substance use disorder patients
BMC Med. Res. Methodol., 19, 44
DOI 10.1186/s12874-019-0690-3

Muller AE, Skurtveit S, Clausen T (2019)
Confirming the factor structure of a generic quality of life instrument among pre-treatment substance use disorder patients
Health Qual. Life Outcomes, 17, 84
DOI 10.1186/s12955-019-1152-7

Skurtveit S, Nechanska B, Handal M, Mahic M, Mravcik V, Gabrhelik R (2019)
Hospitalization of children after prenatal exposure to opioid maintenance therapy during pregnancy: a national registry study from the Czech Republic
Addiction, 114 (7), 1225-1235
DOI 10.1111/add.14576

Suren P, Bakken IJ, Skurtveit S, Handal M, Reichborn-Kjennerud T, Stoltenberg C, Nostvik LI, Weidle B (2019)
Tourette's syndrome in children in Norway
Tidsskr. Nor. Laegeforen., 139 (17), 1649-1653

Tveito M, Handal M, Engedal K, Smith RL, Hoiseth G, Skurtveit S (2019)
Prescribing antipsychotics to the elderly living at home 2006-2018
Tidsskr. Nor. Laegeforen., 139 (16), 1554-1558

Publications 2018

Egeland GM, Skurtveit S, Staff AC, Eide GE, Daltveit AK, Klungsoyr K, Trogstad L, Magnus PM, Brantsaeter AL, Haugen M (2018)
Pregnancy-Related Risk Factors Are Associated With a Significant Burden of Treated Hypertension Within 10 Years of Delivery: Findings From a Population-Based Norwegian Cohort
J. Am. Heart Assoc., 7 (10), e008318
DOI 10.1161/JAHA.117.008318

Engeland A, Bjorge T, Klungsoyr K, Hjellvik V, Skurtveit S, Furu K (2018)
Trends in prescription drug use during pregnancy and postpartum in Norway, 2005 to 2015
Pharmacoepidemiol. Drug Saf., 27 (9), 995-1004
DOI 10.1002/pds.4577

Heldal AT, Skurtveit S, Lobmaier PPK, Vederhus JK, Bramness JG (2018)
Use of drugs for alcoholic disorders in Norway 2004-16
Tidsskr. Nor. Laegeforen., 138 (18), 1710-1715

Hoff M, Skurtveit S, Meyer HE, Langhammer A, Sogaard AJ, Syversen U, Skovlund E, Abrahamsen B, Forsmo S, Schei B (2018)
Anti-osteoporosis drug use: too little, too much, or just right? The HUNT study, Norway
Osteoporosis Int., 29 (8), 1875-1885
DOI 10.1007/s00198-018-4560-3

Johannsdottir IM, Loge JH, Kiserud CE, Karlstad O, Skurtveit S (2018)
Increased prescription rates of anxiolytics and hypnotics to survivors of cancer in childhood, adolescence, and young adulthoodA population-based study
Pediatr. Blood Cancer, 65 (2), e26860
DOI 10.1002/pbc.26860

Lupattelli A, Wood M, Ystrom E, Skurtveit S, Handal M, Nordeng H (2018)
Effect of Time-Dependent Selective Serotonin Reuptake Inhibitor Antidepressants During Pregnancy on Behavioral, Emotional, and Social Development in Preschool-Aged Children
J. Am. Acad. Child Adolesc. Psychiatr., 57 (3), 200-208
DOI 10.1016/j.jaac.2017.12.010

Mauseth SA, Skurtveit S, Langhammer A, Spigset O (2018)
Incidence of and factors associated with anticholinergic drug use among Norwegian women with urinary incontinence
Int. Urogynecol. J., 29 (4), 489-495
DOI 10.1007/s00192-017-3499-9

Mauseth SA, Skurtveit S, Skovlund E, Langhammer A, Spigset O (2018)
Medication use and association with urinary incontinence in women: Data from the Norwegian Prescription Database and the HUNT study
Neurourol. Urodyn., 37 (4), 1448-1457
DOI 10.1002/nau.23473

Nechanska B, Mravcik V, Skurtveit S, Lund IO, Gabrhelik R, Engeland A, Handal M (2018)
Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway
Addiction, 113 (7), 1286-1294
DOI 10.1111/add.14192

Nesvag R, Bramness JG, Handal M, Hartz I, Hjellvik V, Skurtveit S (2018)
The incidence, psychiatric co-morbidity and pharmacological treatment of severe mental disorders in children and adolescents
Eur. Psychiat., 49, 16-22
DOI 10.1016/j.eurpsy.2017.12.009

Reset A, Skurtveit S, Furu K, Skovlund E (2018)
Effect of the market withdrawal of dextropropoxyphene on use of other prescribed analgesics
Scand. J. Pain, 18 (4), 667-674
DOI 10.1515/sjpain-2018-0103

Skjaervo I, Clausen T, Skurtveit S, Abel KF, Bukten A (2018)
Similarities and Differences in Victimization Risk Factors for Nonoffending and Offending Substance Users
Victims Offenders, 13 (4), 526-541
DOI 10.1080/15564886.2017.1383332

Skurtveit S, Bramness JG, Hjellvik V, Hartz I, Nesvag R, Hauge LJ, Handal M (2018)
Increase in diagnosis of depressive disorders contributes to the increase in antidepressant use in adolescents
Acta Psychiatr. Scand., 137 (5), 413-421
DOI 10.1111/acps.12877

Tverdal A, Skurtveit S, Selmer R, Myhre R, Thelle D (2018)
Coffee and wine consumption is associated with reduced mortality from alcoholic liver disease: follow-up of 219,279 Norwegian men and women aged 30-67 years
Ann. Epidemiol., 28 (11), 753-758
DOI 10.1016/j.annepidem.2018.08.010

Publications 2017

Bachmann CJ, Aagaard L, Bernardo M, Brandt L, Cartabia M, Clavenna A, Fuste AC, Furu K, Garuoliene K, Hoffmann F, Hollingworth S, Huybrechts KF, Kalverdijk LJ, Kawakami K, Kieler H, Kinoshita T, Lopez SC, Machado-Alba JE, Machado-Duque ME, Mahesri M, Nishtala PS, Piovani D, Reutfors J, Saastamoinen LK, Sato I et al. (2017)
International trends in clozapine use: a study in 17 countries
Acta Psychiatr. Scand., 136 (1), 37-51
DOI 10.1111/acps.12742

Bukten A, Stavseth MR, Skurtveit S, Tverdal A, Strang J, Clausen T (2017)
High risk of overdose death following release from prison: variations in mortality during a 15-year observation period
Addiction, 112 (8), 1432-1439
DOI 10.1111/add.13803

Egeland GM, Skurtveit S, Sakshaug S, Daltveit AK, Vikse BE, Haugen M (2017)
Low Calcium Intake in Midpregnancy Is Associated with Hypertension Development within 10 Years after Pregnancy: The Norwegian Mother and Child Cohort Study
J. Nutr., 147 (9), 1757-1763
DOI 10.3945/jn.117.251520

Engeland A, Bjorge T, Klungsoyr K, Skurtveit S, Furu K (2017)
Preterm births and use of medication in early adulthood: a population-based registry study
Pharmacoepidemiol. Drug Saf., 26 (7), 742-751
DOI 10.1002/pds.4174

Evandt J, Oftedal B, Krog NH, Skurtveit S, Nafstad P, Schwarze PE, Skovlund E, Houthuijs D, Aasvang GM (2017)
Road traffic noise and registry based use of sleep medication
Environ. Health, 16, 110
DOI 10.1186/s12940-017-0330-5

Fredheim OMS, Brelin S, Hjermstad MJ, Loge JH, Aass N, Johannesen TB, Skurtveit S (2017)
Prescriptions of analgesics during complete disease trajectories in patients who are diagnosed with and die from cancer within the five-year period 2005-2009
Eur. J. Pain, 21 (3), 530-540
DOI 10.1002/ejp.956

Fredheim OMS, Skurtveit S, Borchgrevink PC (2017)
Delivery of analgesics to children before and after new recommendations on codeine
Tidsskr. Nor. Laegeforen., 137 (12-13), 881-884

Gjersing L, Jonassen K, Skurtveit S, Bramness J, Clausen T (2017)
Emergency service use is common in the year before death among drug users who die from an overdose
J. Subst. Use, 22 (3), 331-336
DOI 10.1080/14659891.2016.1208778

Halfdanarson O, Zoega H, Aagaard L, Bernardo M, Brandt L, Fuste AC, Furu K, Garuoliene K, Hoffmann F, Huybrechts KF, Kalverdijk LJ, Kawakami K, Kieler H, Kinoshita T, Litchfield M, Lopez SC, Machado-Alba JE, Machado-Duque ME, Mahesri M, Nishtala PS, Pearson SA, Reutfors J, Saastamoinen LK, Sato I, Schuiling-Veninga CCM et al. (2017)
International trends in antipsychotic use: A study in 16 countries, 2005-2014
Eur. Neuropsychopharmacol., 27 (10), 1064-1076
DOI 10.1016/j.euroneuro.2017.07.001

Hoff M, Meyer HE, Skurtveit S, Langhammer A, Sogaard AJ, Syversen U, Dhainaut A, Skovlund E, Abrahamsen B, Schei B (2017)
Validation of FRAX and the impact of self-reported falls among elderly in a general population: the HUNT study, Norway
Osteoporosis Int., 28 (10), 2935-2944
DOI 10.1007/s00198-017-4134-9

Johannsdottir IM, Karlstad O, Loge JH, Fossa SD, Kiserud C, Skurtveit S (2017)
Prescriptions of Antidepressants to Survivors of Cancer in Childhood, Adolescence, and Young Adulthood: A Population-Based Study
J. Adolesc. Young Adult Oncol., 6 (1), 120-126
DOI 10.1089/jayao.2016.0041

Muller AE, Skurtveit S, Clausen T (2017)
Building abstinent networks is an important resource in improving quality of life
Drug Alcohol Depend., 180, 431-438
DOI 10.1016/j.drugalcdep.2017.09.006

Rognli EB, Bramness JG, Skurtveit S, Bukten A (2017)
Substance use and sociodemographic background as risk factors for lifetime psychotic experiences in a non-clinical sample
J. Subst. Abus. Treat., 74, 42-47
DOI 10.1016/j.jsat.2016.12.007

Sakshaug S, Handal M, Hjellvik V, Berg C, Ripel A, Gustavsen I, Morland J, Skurtveit S (2017)
Long-term Use of Z-Hypnotics and Co-medication with Benzodiazepines and Opioids
Basic Clin. Pharmacol. Toxicol., 120 (3), 292-298
DOI 10.1111/bcpt.12684

Skjaervo I, Skurtveit S, Clausen T, Bukten A (2017)
Substance use pattern, self-control and social network are associated with crime in a substance-using population
Drug Alcohol Rev., 36 (2), 245-252
DOI 10.1111/dar.12406

Skovlund E, Handal M, Selmer R, Brandlistuen RE, Skurtveit S (2017)
Language competence and communication skills in 3-year-old children after prenatal exposure to analgesic opioids
Pharmacoepidemiol. Drug Saf., 26 (6), 625-634
DOI 10.1002/pds.4170

Publications 2016

Gabrhelik R, Nechanska B, Mravcik V, Skurtveit S, Lund IO, Handal M (2016)
A UNIQUE OPPORTUNITY TO STUDY SHORT AND LONG-TERM CONSEQUENCES IN CHILDREN PRENATALLY EXPOSED TO ILLICIT DRUGS AND OPIOID MAINTENANCE TREATMENT USING CZECH AND SCANDINAVIAN REGISTERS
Cent. Eur. J. Public Health, 24 (3), 248-251
DOI 10.21101/cejph.a4474

Handal M, Skurtveit S, Furu K, Hernandez-Diaz S, Skovlund E, Nystad W, Selmer R (2016)
Motor development in children prenatally exposed to selective serotonin reuptake inhibitors: a large population-based pregnancy cohort study
BJOG, 123 (12), 1908-1917
DOI 10.1111/1471-0528.13582

Handal M, Skurtveit S, Roth C, Hernandez-Diaz S, Selmer R (2016)
Prenatal Exposure to Folic Acid and Antidepressants and Language Development A Population-Based Cohort Study
J. Clin. Psychopharmacol., 36 (4), 333-339
DOI 10.1097/JCP.0000000000000519

Hansen AB, Borchgrevink PC, Skurtveit S, Romundstad P, Fredheim OM (2016)
Consumption of and satisfaction with health care among opioid users with chronic non-malignant pain
Acta Anaesthesiol. Scand., 60 (2), 276
DOI 10.1111/aas.12645

Hartz I, Skurtveit S, Hjellvik V, Furu K, Nesvag R, Handal M (2016)
Antidepressant drug use among adolescents during 2004-2013: a population-based register linkage study
Acta Psychiatr. Scand., 134 (5), 420-429
DOI 10.1111/acps.12633

Hartz I, Skurtveit S, Steffenak AKM, Karlstad O, Handal M (2016)
Psychotropic drug use among 0-17 year olds during 2004-2014: a nationwide prescription database study
BMC Psychiatry, 16, 12
DOI 10.1186/s12888-016-0716-x

Mellbye A, Karlstad O, Skurtveit S, Borchgrevink PC, Fredheim OMS (2016)
The duration and course of opioid therapy in patients with chronic non-malignant pain
Acta Anaesthesiol. Scand., 60 (1), 128-137
DOI 10.1111/aas.12594

Midgard H, Bramness JG, Skurtveit S, Haukeland JW, Dalgard O (2016)
Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study
PLoS One, 11 (11), e0166451
DOI 10.1371/journal.pone.0166451

Muller AE, Skurtveit S, Clausen T (2016)
Many correlates of poor quality of life among substance users entering treatment are not addiction-specific
Health Qual. Life Outcomes, 14, 39
DOI 10.1186/s12955-016-0439-1

Muller AE, Skurtveit S, Clausen T (2016)
Validating the generic quality of life tool "QOL10" in a substance use disorder treatment cohort exposes a unique social construct
BMC Med. Res. Methodol., 16, 60
DOI 10.1186/s12874-016-0163-x

Nesvag R, Hartz I, Bramness JG, Hjellvik V, Handal M, Skurtveit S (2016)
Mental disorder diagnoses among children and adolescents who use antipsychotic drugs
Eur. Neuropsychopharmacol., 26 (9), 1412-1418
DOI 10.1016/j.euroneuro.2016.07.001

Tjagvad C, Clausen T, Handal M, Skurtveit S (2016)
Benzodiazepine prescription for patients in treatment for drug use disorders: a nationwide cohort study in Denmark, 2000-2010
BMC Psychiatry, 16, 168
DOI 10.1186/s12888-016-0881-y

Tjagvad C, Skurtveit S, Bramness JG, Gjersing L, Gossop M, Clausen T (2016)
Misuse of prescription drugs and overdose deaths
J. Subst. Use, 21 (5), 515-520
DOI 10.3109/14659891.2015.1077280

Tjagvad C, Skurtveit S, Linnet K, Andersen LV, Christoffersen DJ, Clausen T (2016)
Methadone-Related Overdose Deaths in a Liberal Opioid Maintenance Treatment Programme
Eur. Addict. Res., 22 (5), 249-258
DOI 10.1159/000446429

Publications 2015

Berg C, Skurtveit S, Sakshaug S, Hjellvik V, Handal M (2015)
Reduced Prescribing of Benzodiazepines in Denmark and Norway
Basic Clin. Pharmacol. Toxicol., 116 (6), 457-458
DOI 10.1111/bcpt.12377

Bukten A, Lund IO, Rognli EB, Stavseth MR, Lobmaier P, Skurtveit S, Clausen T, Kunoe N (2015)
The Norwegian Offender Mental Health and Addiction Study - Design and Implementation of a National Survey and Prospective Cohort Study
Subst. Abus.-Res. Treat., 9 2, 59-66
DOI 10.4137/SART.S23546

Dale O, Borchgrevink PC, Fredheim OMS, Mahic M, Romundstad P, Skurtveit S (2015)
Prevalence of use of non-prescription analgesics in the Norwegian HUNT3 population: Impact of gender, age, exercise and prescription of opioids
BMC Public Health, 15, 461
DOI 10.1186/s12889-015-1774-6

Engeland A, Bjorge T, Klungsoyr K, Skjaerven R, Skurtveit S, Furu K (2015)
Preeclampsia in pregnancy and later use of antihypertensive drugs
Eur. J. Epidemiol., 30 (6), 501-508
DOI 10.1007/s10654-015-0018-5

Fredheim OMS, Mahic M, Skurtveit S, Borchgrevink PC (2015)
Use of nasal fentanyl for cancer pain: A pharmacoepidemiological study
Palliat. Med., 29 (7), 661-666
DOI 10.1177/0269216315575252

Hansen AB, Skurtveit S, Borchgrevink PC, Dale O, Romundstad PR, Mahic M, Fredheim OM (2015)
Consumption of and satisfaction with health care among opioid users with chronic non-malignant pain
Acta Anaesthesiol. Scand., 59 (10), 1355-1366
DOI 10.1111/aas.12568

Hartz I, Handal M, Tverdal A, Skurtveit S (2015)
Paediatric Off-Label Use of Melatonin - A Register Linkage Study between the Norwegian Prescription Database and Patient Register
Basic Clin. Pharmacol. Toxicol., 117 (4), 267-273
DOI 10.1111/bcpt.12411

Hoff M, Skurtveit S, Meyer HE, Langhammer A, Sogaard AJ, Syversen U, Abrahamsen B, Schei B (2015)
Use of anti-osteoporotic drugs in central Norway after a forearm fracture
Arch. Osteoporos., 10 (1), 30
DOI 10.1007/s11657-015-0235-2

Lund IO, Bukten A, Storvoll EE, Moan IS, Skurtveit S, Handal M, Nordfjaern T, Brunborg GS, Rossow I (2015)
A Cohort Study on Long-Term Adverse Effects of Parental Drinking: Background and Study Design
Subst. Abus.-Res. Treat., 9 2, UNSP SART.S23329-83
DOI 10.4137/SART.S23329

Lund IO, Skurtveit S, Handal M (2015)
Commentary on Raitasalo et al. (2015): The great potential in nation-wide registers to study prescription drug use and abuse
Addiction, 110 (4), 644-645
DOI 10.1111/add.12856

Mahic M, Fredheim OM, Borchgrevink PC, Skurtveit S (2015)
Use of prescribed opioids by children and adolescents: Differences between Denmark, Norway and Sweden
Eur. J. Pain, 19 (8), 1095-1100
DOI 10.1002/ejp.632

Odsbu I, Skurtveit S, Selmer R, Roth C, Hernandez-Diaz S, Handal M (2015)
Prenatal exposure to anxiolytics and hypnotics and language competence at 3 years of age
Eur. J. Clin. Pharmacol., 71 (3), 283-291
DOI 10.1007/s00228-014-1797-4

Welle-Strand GK, Skurtveit S, Tanum L, Waal H, Bakstad B, Bjarko L, Ravndal E (2015)
Tapering from Methadone or Buprenorphine during Pregnancy: Maternal and Neonatal Outcomes in Norway 1996-2009
Eur. Addict. Res., 21 (5), 253-261
DOI 10.1159/000381670

Publications 2014

Bukten A, Skurtveit S, Waal H, Clausen T (2014)
Factors associated with dropout among patients in opioid maintenance treatment (OMT) and predictors of re-entry. A national registry-based study
Addict. Behav., 39 (10), 1504-1509
DOI 10.1016/j.addbeh.2014.05.007

Fredheim OMS, Mahic M, Skurtveit S, Dale O, Romundstad P, Borchgrevink PC (2014)
Chronic pain and use of opioids: A population-based pharmacoepidemiological study from the Norwegian Prescription Database and the Nord-Trondelag Health Study
Pain, 155 (7), 1213-1221
DOI 10.1016/j.pain.2014.03.009

Karlstad O, Furu K, Skurtveit S, Selmer R (2014)
Prescribing of Drugs for Attention-Deficit Hyperactivity Disorder in Opioid Maintenance Treatment Patients in Norway
Eur. Addict. Res., 20 (2), 59-65
DOI 10.1159/000353969

Mellbye A, Karlstad O, Skurtveit S, Borchgrevink PC, Fredheim OMS (2014)
Co-morbidity in persistent opioid users with chronic non-malignant pain in Norway
Eur. J. Pain, 18 (8), 1083-1093
DOI 10.1002/j.1532-2149.2014.00449.x

Neutel CI, Skurtveit S, Berg C, Sakshaug S (2014)
Trends in prescription of strong opioids for 41-80 year old Norwegians, 2005-2010
Eur. J. Pain, 18 (3), 438-446
DOI 10.1002/j.1532-2149.2013.00374.x

Riska BS, Skurtveit S, Furu K, Engeland A, Handal M (2014)
Dispensing of benzodiazepines and benzodiazepine-related drugs to pregnant women: a population-based cohort study
Eur. J. Clin. Pharmacol., 70 (11), 1367-1374
DOI 10.1007/s00228-014-1744-4

Skurtveit S, Selmer R, Roth C, Hernandez-Diaz S, Handal M (2014)
Prenatal exposure to antidepressants and language competence at age three: results from a large population-based pregnancy cohort in Norway
BJOG, 121 (13), 1621-1631
DOI 10.1111/1471-0528.12821

Svendsen K, Fredheim OM, Romundstad P, Borchgrevink PC, Skurtveit S (2014)
Persistent opioid use and socio- economic factors: a population- based study in Norway
Acta Anaesthesiol. Scand., 58 (4), 437-445
DOI 10.1111/aas.12281

Publications 2013

Brelin S, Loge JH, Skurtveit S, Johannesen TB, Aass N, Ottesen S, Hjermstad MJ (2013)
Antidepressants to cancer patients during the last year of life-a population-based study
Psycho-Oncol., 22 (3), 506-514
DOI 10.1002/pon.3059

Bukten A, Herskedal A, Skurtveit S, Bramness JG, Clausen T (2013)
Driving under the influence (DUI) among patients in opioid maintenance treatment (OMT): a registry-based national cohort study
Addiction, 108 (11), 1954-1961
DOI 10.1111/add.12275

Bukten A, Roislien J, Skurtveit S, Waal H, Gossop M, Clausen T (2013)
A day-by-day investigation of changes in criminal convictions before and after entering and leaving opioid maintenance treatment: a national cohort study
BMC Psychiatry, 13, 262
DOI 10.1186/1471-244X-13-262

Engeland A, Bjorge T, Daltveit AK, Skurtveit S, Vangen S, Vollset SE, Furu K (2013)
Effects of preconceptional paternal drug exposure on birth outcomes: cohort study of 340000 pregnancies using Norwegian population-based databases
Br. J. Clin. Pharmacol., 75 (4), 1134-1141
DOI 10.1111/j.1365-2125.2012.04426.x

Fredheim OMS, Borchgrevink PC, Mahic M, Skurtveit S (2013)
A pharmacoepidemiological cohort study of subjects starting strong opioids for nonmalignant pain: A study from the Norwegian Prescription Database
Pain, 154 (11), 2487-2493
DOI 10.1016/j.pain.2013.07.033

Holdo I, Handal M, Skurtveit S, Bramness JG (2013)
Association between prescribing hypnotics for parents and children in Norway
Arch. Dis. Child., 98 (9), 732-736
DOI 10.1136/archdischild-2013-303646

Log T, Skurtveit S, Selmer R, Tverdal A, Furu K, Hartz I (2013)
The association between prescribed opioid use for mothers and children: a record-linkage study
Eur. J. Clin. Pharmacol., 69 (1), 111-118
DOI 10.1007/s00228-012-1312-8

Lund IO, Skurtveit S, Engeland A, Furu K, Ravndal E, Handal M (2013)
Prescription drug use among pregnant women in opioid Maintenance Treatment
Addiction, 108 (2), 367-376
DOI 10.1111/j.1360-0443.2012.04049.x

Lund IO, Skurtveit S, Sarfi M, Bakstad B, Welle-Strand G, Ravndal E (2013)
A 2-year prospective study of psychological distress among a national cohort of pregnant women in opioid maintenance treatment and their partners
J. Subst. Use, 18 (2), 148-160
DOI 10.3109/14659891.2011.642928

Mauseth SA, Skurtveit S, Spigset O (2013)
Adherence, persistence and switch rates for anticholinergic drugs used for overactive bladder in women: data from the Norwegian Prescription Database
Acta Obstet. Gynecol. Scand., 92 (10), 1208-1215
DOI 10.1111/aogs.12196

Neutel CI, Skurtveit S, Berg C, Sakshaug S (2013)
MULTIPLE PRESCRIBERS IN OLDER FREQUENT OPIOID USERS - DOES IT MEAN ABUSE?
J. Popul. Ther. Clin. Pharmacol., 20 (3), E397-E405

Skollerud LM, Fredheim OMS, Svendsen K, Skurtveit S, Borchgrevink PC (2013)
Laxative prescriptions to cancer outpatients receiving opioids: a study from the Norwegian prescription database
Support. Care Cancer, 21 (1), 67-73
DOI 10.1007/s00520-012-1494-8

Skurtveit S, Selmer R, Tverdal A, Furu K, Nystad W, Handal M (2013)
Drug exposure: inclusion of dispensed drugs before pregnancy may lead to underestimation of risk associations
J. Clin. Epidemiol., 66 (9), 964-972
DOI 10.1016/j.jclinepi.2013.02.011

Welle-Strand GK, Skurtveit S, Jansson LM, Bakstad B, Bjarko L, Ravndal E (2013)
Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants
Acta Paediatr., 102 (11), 1060-1066
DOI 10.1111/apa.12378

Welle-Strand GK, Skurtveit S, Jones HE, Waal H, Bakstad B, Bjarko L, Ravndal E (2013)
Neonatal outcomes following in utero exposure to methadone or buprenorphine: A National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009
Drug Alcohol Depend., 127 (1-3), 200-206
DOI 10.1016/j.drugalcdep.2012.07.001

Publications 2012

Bramness JG, Furu K, Skurtveit S, Engeland A (2012)
Effect of the Market Withdrawal of Carisoprodol on Use of Other Prescribed Drugs With Abuse Potential
Clin. Pharmacol. Ther., 91 (3), 438-441
DOI 10.1038/clpt.2011.250

Bramness JG, Skurtveit S, Morland J, Engeland A (2012)
An increased risk of motor vehicle accidents after prescription of methadone
Addiction, 107 (5), 967-972
DOI 10.1111/j.1360-0443.2011.03745.x

Bukten A, Skurtveit S, Gossop M, Waal H, Stangeland P, Havnes I, Clausen T (2012)
Engagement with opioid maintenance treatment and reductions in crime: a longitudinal national cohort study
Addiction, 107 (2), 393-399
DOI 10.1111/j.1360-0443.2011.03637.x

Devold HM, Furu K, Skurtveit S, Tverdal A, Falch JA, Sogaard AJ (2012)
Influence of socioeconomic factors on the adherence of alendronate treatment in incident users in Norway
Pharmacoepidemiol. Drug Saf., 21 (3), 297-304
DOI 10.1002/pds.2344

Fredheim OMS, Moksnes K, Borchgrevink PC, Skurtveit S (2012)
Opioid switching to methadone: A pharmacoepidemiological study from a national prescription database
Palliat. Med., 26 (6), 804-812
DOI 10.1177/0269216311412415

Hartz I, Furu K, Bratlid T, Handal M, Skurtveit S (2012)
Hypnotic drug use among 0-17 year olds during 2004-2011: A nationwide prescription database study
Scand. J. Public Health, 40 (8), 704-711
DOI 10.1177/1403494812464446

Karlstad O, Nafstad P, Tverdal A, Skurtveit S, Furu K (2012)
Comorbidities in an asthma population 8-29 years old: a study from the Norwegian Prescription Database
Pharmacoepidemiol. Drug Saf., 21 (10), 1045-1052
DOI 10.1002/pds.2233

Lund IO, Skurtveit S, Sarfi M, Bakstad B, Welle-Strand G, Ravndal E (2012)
Substance use during and after pregnancy among a national cohort of pregnant women in opioid maintenance treatment and their partners
J. Subst. Use, 17 (3), 277-286
DOI 10.3109/14659891.2011.580415

Mellbye A, Svendsen K, Borchgrevink PC, Skurtveit S, Fredheim OMS (2012)
Concomitant medication among persistent opioid users with chronic non-malignant pain
Acta Anaesthesiol. Scand., 56 (10), 1267-1276
DOI 10.1111/j.1399-6576.2012.02766.x

Neutel CI, Skurtveit S, Berg C (2012)
Polypharmacy of potentially addictive medication in the older personsuquantifying usage
Pharmacoepidemiol. Drug Saf., 21 (2), 199-206
DOI 10.1002/pds.2214

Neutel CI, Skurtveit S, Berg C (2012)
What is the point of guidelines? Benzodiazepine and z-hypnotic use by an elderly population
Sleep Med., 13 (7), 893-897
DOI 10.1016/j.sleep.2011.12.014

Nordbo A, Skurtveit S, Borchgrevink PC, Kaasa S, Fredheim OM (2012)
Low-dose transdermal buprenorphine - long-term use and co-medication with other potentially addictive drugs
Acta Anaesthesiol. Scand., 56 (1), 88-94
DOI 10.1111/j.1399-6576.2011.02537.x

Steffenak AKM, Nordstrom G, Wilde-Larsson B, Skurtveit S, Furu K, Hartz I (2012)
Mental Distress and Subsequent Use of Psychotropic Drugs Among Adolescents-A Prospective Register Linkage Study
J. Adolesc. Health, 50 (6), 578-587
DOI 10.1016/j.jadohealth.2011.10.011

Svendsen K, Skurtveit S, Romundstad P, Borchgrevink PC, Fredheim OMS (2012)
Differential patterns of opioid use: Defining persistent opioid use in a prescription database
Eur. J. Pain, 16 (3), 359-369
DOI 10.1002/j.1532-2149.2011.00018.x

Publications 2011

Bukten A, Skurtveit S, Stangeland P, Gossop M, Willersrud AB, Waal H, Havnes I, Clausen T (2011)
Criminal convictions among dependent heroin users during a 3-year period prior to opioid maintenance treatment.: A longitudinal national cohort study
J. Subst. Abus. Treat., 41 (4), 407-414
DOI 10.1016/j.jsat.2011.06.006

Engeland A, Bjorge T, Daltveit AK, Skurtveit S, Vangen S, Vollset SE, Furu K (2011)
Risk of diabetes after gestational diabetes and preeclampsia. A registry-based study of 230,000 women in Norway
Eur. J. Epidemiol., 26 (2), 157-163
DOI 10.1007/s10654-010-9527-4

Fredheim OMS, Borchgrevink PC, Nordstrand B, Clausen T, Skurtveit S (2011)
Prescription of analgesics to patients in opioid maintenance therapy: A pharmacoepidemiological study
Drug Alcohol Depend., 116 (1-3), 158-162
DOI 10.1016/j.drugalcdep.2010.12.014

Furu K, Karlstad O, Skurtveit S, Haberg SE, Nafstad P, London SJ, Nystad W (2011)
High validity of mother-reported use of antiasthmatics among children: a comparison with a population-based prescription database
J. Clin. Epidemiol., 64 (8), 878-884
DOI 10.1016/j.jclinepi.2010.10.014

Handal M, Engeland A, Ronning M, Skurtveit S, Furu K (2011)
Use of prescribed opioid analgesics and co-medication with benzodiazepines in women before, during, and after pregnancy: a population-based cohort study
Eur. J. Clin. Pharmacol., 67 (9), 953-960
DOI 10.1007/s00228-011-1030-7

Karlstad O, Tverdal A, Skurtveit S, Nafstad P, Furu K (2011)
A prospective study of asthma and subsequent use of hypnotics in young adults
Pharmacoepidemiol. Drug Saf., 20 (4), 370-377
DOI 10.1002/pds.2101

Log T, Hartz I, Handal M, Tverdal A, Furu K, Skurtveit S (2011)
The association between smoking and subsequent repeated use of prescribed opioids among adolescents and young adults-a population-based cohort study
Pharmacoepidemiol. Drug Saf., 20 (1), 90-98
DOI 10.1002/pds.2066

Log T, Skurtveit S, Tverdal A, Furu K, Hartz I (2011)
Dispensing of prescribed analgesics in Norway among young people with foreign- or Norwegian-born parents
Scand. J. Pain, 2 (1), 36-44
DOI 10.1016/j.sjpain.2010.11.001

Mahic M, Skurtveit S, Selmer R, Ronning M, Furu K (2011)
Prevalence, incidence and persistence of etanercept and adalimumab in Norway 2005-2009
Pharmacoepidemiol. Drug Saf., 20 (5), 457-463
DOI 10.1002/pds.2091

Skurtveit S, Furu K, Borchgrevink P, Handal M, Fredheim O (2011)
To what extent does a cohort of new users of weak opioids develop persistent or probable problematic opioid use?
Pain, 152 (7), 1555-1561
DOI 10.1016/j.pain.2011.02.045

Publications 2010

Bramness JG, Sandvik P, Engeland A, Skurtveit S (2010)
Does Pregabalin (Lyrica (R)) Help Patients Reduce their Use of Benzodiazepines? A Comparison with Gabapentin using the Norwegian Prescription Database
Basic Clin. Pharmacol. Toxicol., 107 (5), 883-886
DOI 10.1111/j.1742-7843.2010.00590.x

Fredheim OMS, Log T, Olsen W, Skurtveit S, Sagen O, Borchgrevink PC (2010)
Prescriptions of opioids to children and adolescents; a study from a national prescription database in Norway
Pediatr. Anesth., 20 (6), 537-544
DOI 10.1111/j.1460-9592.2010.03310.x

Fredheim OMS, Skurtveit S, Breivik H, Borchgrevink PC (2010)
Increasing use of opioids from 2004 to 2007-Pharmacoepidemiological data from a complete national prescription database in Norway
Eur. J. Pain, 14 (3), 289-294
DOI 10.1016/j.ejpain.2009.05.006

Hartz I, Tverdal A, Skille E, Skurtveit S (2010)
Disability pension as predictor of later use of benzodiazepines among benzodiazepine users
Soc. Sci. Med., 70 (6), 921-925
DOI 10.1016/j.socscimed.2009.11.015

Hausken AM, Furu K, Tverdal A, Skurtveit S (2010)
Mental distress and subsequent use of anxiolytic drugs - A prospective population-based cohort study of 16,000 individuals
Scand. J. Public Health, 38 (5), 465-473
DOI 10.1177/1403494810370229

Karlstad O, Nafstad P, Tverdal A, Skurtveit S, Furu K (2010)
Prevalence, incidence and persistence of anti-asthma medication use in 2-to 29-year-olds: a nationwide prescription study
Eur. J. Clin. Pharmacol., 66 (4), 399-406
DOI 10.1007/s00228-009-0749-x

Skurtveit S, Furu K, Bramness J, Selmer R, Tverdal A (2010)
Benzodiazepines Predict Use of Opioids-A Follow-Up Study of 17,074 Men and Women
Pain Med., 11 (6), 805-814
DOI 10.1111/j.1526-4637.2010.00870.x

Skurtveit S, Furu K, Selmer R, Handal M, Tverdal A (2010)
Nicotine Dependence Predicts Repeated Use of Prescribed Opioids. Prospective Population-based Cohort Study
Ann. Epidemiol., 20 (12), 890-897
DOI 10.1016/j.annepidem.2010.03.010

Publications 2009

Bachs LC, Engeland A, Morland JG, Skurtveit S (2009)
The Risk of Motor Vehicle Accidents Involving Drivers With Prescriptions for Codeine or Tramadol
Clin. Pharmacol. Ther., 85 (6), 596-599
DOI 10.1038/clpt.2009.14

Bramness JG, Skurtveit S, Neutel CI, Morland J, Engeland A (2009)
An increased risk of road traffic accidents after prescriptions of lithium or valproate?
Pharmacoepidemiol. Drug Saf., 18 (6), 492-496
DOI 10.1002/pds.1740

Devold HM, Molden E, Skurtveit S, Furu K (2009)
Co-medication of statins and CYP3A4 inhibitors before and after introduction of new reimbursement policy
Br. J. Clin. Pharmacol., 67 (2), 234-241
DOI 10.1111/j.1365-2125.2008.03345.x

Fredheim OMS, Skurtveit S, Moroz A, Breivik H, Borchgrevink PC (2009)
Prescription pattern of codeine for non-malignant pain: a pharmacoepidemiological study from the Norwegian Prescription Database
Acta Anaesthesiol. Scand., 53 (5), 627-633
DOI 10.1111/j.1399-6576.2009.01910.x

Hartz I, Lundesgaard E, Tverdal A, Skurtveit S (2009)
Disability pension is associated with the use of benzodiazepines 20 years later: A prospective study
Scand. J. Public Health, 37 (3), 320-326
DOI 10.1177/1403494808101372

Hausken A, Furu K, Skurtveit S, Engeland A, Bramness J (2009)
Starting insomnia treatment: the use of benzodiazepines versus z-hypnotics. A prescription database study of predictors
Eur. J. Clin. Pharmacol., 65 (3), 295-301
DOI 10.1007/s00228-008-0565-8

Selmer R, Sakshaug S, Skurtveit S, Furu K, Tverdal A (2009)
Statin treatment in a cohort of 20 212 men and women in Norway according to cardiovascular risk factors and level of education
Br. J. Clin. Pharmacol., 67 (3), 355-362
DOI 10.1111/j.1365-2125.2008.03360.x

Skurtveit S, Furu K, Kaasa S, Borchgrevink PC (2009)
Introduction of low dose transdermal buprenorphine - Did it influence use of potentially addictive drugs in chronic non-malignant pain patients?
Eur. J. Pain, 13 (9), 949-953
DOI 10.1016/j.ejpain.2008.11.005

Skurtveit S, Strom H, Skrivarhaug T, Morland J, Bramness JG, Engeland A (2009)
Road traffic accident risk in patients with diabetes mellitus receiving blood glucose-lowering drugs. Prospective follow-up study
Diabetic Med., 26 (4), 404-408
DOI 10.1111/j.1464-5491.2009.02699.x

Publications 2008

Bramness JG, Skurtveit S (2008)
Carisoprodol Should be Taken Off the Market
South.Med.J., 101 (10), 1074-1075
DOI 10.1097/SMJ.0b013e318184ac60

Bramness JG, Skurtveit S, Gustavsen I, Morland J (2008)
The absence of evidence is not the same as evidence for absence!
Addiction, 103 (3), 513-514
DOI 10.1111/j.1360-0443.2007.02103.x

Engeland A, Bramness JG, Daltveit AK, Ronning M, Skurtveit S, Furu K (2008)
Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106 000 pregnancies in Norway 2004-2006
Br. J. Clin. Pharmacol., 65 (5), 653-660
DOI 10.1111/j.1365-2125.2008.03102.x

Grung M, Kallqvist T, Sakshaug S, Skurtveit S, Thomas KV (2008)
Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline
Ecotox. Environ. Safe., 71 (2), 328-340
DOI 10.1016/j.ecoenv.2007.10.015

Gustavsen I, Brarnness JG, Skurtveit S, Engeland A, Neutel I, Morland J (2008)
Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam
Sleep Med., 9 (8), 818-822
DOI 10.1016/j.sleep.2007.11.011

Handal M, Ripel A, Skurtveit S, Morland J (2008)
Behavioural sensitization in mice induced by morphine-glucuronide metabolites
Pharmacol. Biochem. Behav., 90 (4), 578-585
DOI 10.1016/j.pbb.2008.04.018

Skurtveit S, Furu K, Bramness JG, Tverdal A (2008)
Benzodiazepine use in all alcohol consumers predicts use of opioids in patients 20 years later - a follow-up study of 13 390 men and women aged 40-42 years
Pharmacoepidemiol. Drug Saf., 17 (9), 926-933
DOI 10.1002/pds.1616

Skurtveit S, Selmer R, Tverdal A, Furu K (2008)
The validity of self-reported prescription medication use among adolescents varied by therapeutic class
J. Clin. Epidemiol., 61 (7), 714-717
DOI 10.1016/j.jclinepi.2007.11.013

Publications 2007

Bramness JG, Furu K, Engeland A, Skurtveit S (2007)
Carisoprodol use and abuse in Norway. A pharmacoepidemiological study
Br. J. Clin. Pharmacol., 64 (2), 210-218
DOI 10.1111/j.1365-2125.2007.02847.x

Bramness JG, Skurtveit S, Morland J, Engeland A (2007)
The risk of traffic accidents after prescriptions of carisoprodol
Accid. Anal. Prev., 39 (5), 1050-1055
DOI 10.1016/j.aap.2007.02.002

Engeland A, Skurtveit S, Morland J (2007)
Risk of road traffic accidents associated with the prescription of drugs: A registry-based cohort study
Ann. Epidemiol., 17 (8), 597-602
DOI 10.1016/j.annepidem.2007.03.009

Furu K, Skurtveit S, Langhammer A, Nafstad P (2007)
Use of anti-asthmatic medications as a proxy for prevalence of asthma in children and adolescents in Norway: a nationwide prescription database analysis
Eur. J. Clin. Pharmacol., 63 (7), 693-698
DOI 10.1007/s00228-007-0301-9

Graff-Iversen S, Selmer R, Sorensen M, Skurtveit S (2007)
Occupational physical activity, overweight, and mortality: A follow-up study of 47,405 Norwegian women and men
Res. Q. Exerc. Sport, 78 (3), 151-161

Handal M, Ripel A, Aasmundstad T, Skurtveit S, Morland J (2007)
Morphine-3-glucuronide inhibits morphine induced, but enhances morphine-6-glucuronide induced locomotor activity in mice
Pharmacol. Biochem. Behav., 86 (3), 576-586
DOI 10.1016/j.pbb.2007.02.001

Hausken AM, Skurtveit S, Rosvold EO, Bramness JG, Furu K (2007)
Psychotropic drug use among persons with mental distress symptoms: A population-based study in Norway
Scand. J. Public Health, 35 (4), 356-364
DOI 10.1080/14034940601159161

Hausken AM, Skurtveit S, Tverdal A (2007)
Use of anxiolytic or hypnotic drugs and total mortality in a general middle-aged population
Pharmacoepidemiol. Drug Saf., 16 (8), 913-918
DOI 10.1002/pds.1417

Heiberg E, Skurtveit S, Helsing E, Chalmers B (2007)
Women's experiences of giving birth in Northwest Russia in 2000 and 2002 and in Northern Norway 2000
Acta Obstet. Gynecol. Scand., 86 (3), 373-375
DOI 10.1080/00016340601124144

Sakshaug S, Furu K, Karlstad O, Ronning M, Skurtveit S (2007)
Switching statins in Norway after new reimbursement policy - a nationwide prescription study
Br. J. Clin. Pharmacol., 64 (4), 476-481
DOI 10.1111/j.1365-2125.2007.02907.x

Publications 2006

Bachs L, Hoiseth G, Skurtveit S, Morland J (2006)
Heroin-using drivers: importance of morphine and morphine-6-glucuronide on late clinical impairment
Eur. J. Clin. Pharmacol., 62 (11), 905-912
DOI 10.1007/s00228-006-0195-y

Hartz I, Njolstad I, Furu K, Skurtveit S, Eggen AE (2006)
Why do sales of lipid-lowering drugs vary between counties in Norway? Evidence from the OPPHED Health Study 2000-2001
Scand. J. Prim. Health Care, 24 (2), 115-121
DOI 10.1080/02813430500475365

Publications 2005

Amundsen EJ, Rossow I, Skurtveit S (2005)
Drinking pattern among adolescents with immigrant and Norwegian backgrounds: A two-way influence?
Addiction, 100 (10), 1453-1463
DOI 10.1111/j.1360-0443.2005.01177.x

Bramness JG, Skurtveit S, Gulliksen M, Breilid H, Steen VM, Morland J (2005)
The CYP2C19 genotype and the use of oral contraceptives influence the pharmacokinetics of carisoprodol in healthy human subjects
Eur. J. Clin. Pharmacol., 61 (7), 499-506
DOI 10.1007/s00228-005-0970-1

Hausken AM, Skurtveit S, Christophersen AS (2005)
Mortality among subjects previously apprehended for driving under the influence of traffic-hazardous medicinal drugs
Drug Alcohol Depend., 79 (3), 423-429
DOI 10.1016/j.drugalcdep.2005.03.014

Kristoffersen L, Skuterud B, Larssen BR, Skurtveit S, Smith-Kielland A (2005)
Fast quantification of ethanol in whole blood specimens by the enzymatic alcohol dehydrogenase method. Optimization by experimental design
J. Anal. Toxicol., 29 (1), 66-70
DOI 10.1093/jat/29.1.66

Skurtveit S, Rosvold EO, Furu K (2005)
Use of psychotropic drugs in an urban adolescent population: the impact of health-related variables, lifestyle and sociodemographic factors - The Oslo Health Study 2000-2001
Pharmacoepidemiol. Drug Saf., 14 (4), 277-283
DOI 10.1002/pds.1078

Publications 2004

Bramness JG, Skurtveit S, Morland J (2004)
Impairment due to intake of carisoprodol
Drug Alcohol Depend., 74 (3), 311-318
DOI 10.1016/j.drugalcdep.2004.01.007

Tonstad S, Furu K, Rosvold EO, Skurtveit S (2004)
Determinants of control of high blood pressure. The Oslo Health Study 2000-2001
Blood Pressure, 13 (6), 343-349
DOI 10.1080/08037050410003982

Tonstad S, Rosvold EO, Furu K, Skurtveit S (2004)
Undertreatment and overtreatment with statins: the Oslo Health Study 2000-2001
J. Intern. Med., 255 (4), 494-502
DOI 10.1111/j.1365-2796.2004.01315.x

Publications 2003

Bachs L, Skurtveit S, Morland J (2003)
Codeine and clinical impairment in samples in which morphine is not detected
Eur. J. Clin. Pharmacol., 58 (12), 785-789
DOI 10.1007/s00228-003-0561-y

Bramness JG, Skurtveit S, Fauske L, Grung M, Molven A, Morland J, Steen VM (2003)
Association between blood carisoprodol: meprobamate concentration ratios and CYP2C19 genotype in carisoprodol-drugged drivers: decreased metabolic capacity in heterozygous CYP2C19*1/CYP2C19*2 subjects?
Pharmacogenetics, 13 (7), 383-388
DOI 10.1097/00008571-200307000-00003

Bramness JG, Skurtveit S, Morland J (2003)
Testing for benzodiazepine inebriation-relationship between benzodiazepine concentration and simple clinical tests for impairment in a sample of drugged drivers
Eur. J. Clin. Pharmacol., 59 (8-9), 593-601
DOI 10.1007/s00228-003-0677-0

Skurtveit S, Tverdal A (2003)
Sex differences in gamma-glutamyltransferase in people aged 40-42 years in two Norwegian counties (vol 67, pg 95, 2002)
Drug Alcohol Depend., 69 (1), PII S0376-8716(02)00318-6-+
DOI 10.1016/S0376-8716(02)00318-6

Tverdal A, Skurtveit S (2003)
Coffee intake and mortality from liver cirrhosis
Ann. Epidemiol., 13 (6), 419-423
DOI 10.1016/S1047-2797(02)00462-3

Publications 2002

Bramness JG, Skurtveit S, Morland J (2002)
Clinical impairment of benzodiazepines - relation between benzodiazepine concentrations and impairment in apprehended drivers
Drug Alcohol Depend., 68 (2), 131-141
DOI 10.1016/S0376-8716(02)00188-6

Christophersen AS, Skurtveit S, Grung M, Morland J (2002)
Rearrest rates among Norwegian drunken drugged drivers compared with drivers
Drug Alcohol Depend., 66 (1), 85-92
DOI 10.1016/S0376-8716(01)00187-9

Handal M, Grung M, Skurtveit S, Ripel A, Morland J (2002)
Pharmacokinetic differences of morphine and morphine-glucuronides are reflected in locomotor activity
Pharmacol. Biochem. Behav., 73 (4), PII S0091-3057(02)00925-5-892
DOI 10.1016/S0091-3057(02)00925-5

Skurtveit S, Abotnes B, Christophersen AS (2002)
Drugged drivers in Norway with benzodiazepine detections
Forensic Sci.Int., 125 (1), PII S0379-0738(01)00623-5-82
DOI 10.1016/S0379-0738(01)00623-5

Skurtveit S, Christophersen AS, Grung M, Morland J (2002)
Increased mortality among previously apprehended drunken and drugged drivers
Drug Alcohol Depend., 68 (2), PII S0376-8716(02)00185-0-150
DOI 10.1016/S0376-8716(02)00185-0

Skurtveit S, Tverdal A (2002)
Sex differences in gamma-glutamyltransferase in people aged 40-42 years in two Norwegian counties
Drug Alcohol Depend., 67 (1), PII S0376-8716(02)00015-7-98
DOI 10.1016/S0376-8716(02)00015-7

Publications 2000

Grung M, Skurtveit S, Ripel S, Morland J (2000)
Lack of crosstolerance between morphine and morphine-6-glucuronide as revealed by locomotor activity
Pharmacol. Biochem. Behav., 66 (1), 205-210
DOI 10.1016/S0091-3057(00)00208-2

Publications 1998

Grung M, Skurtveit S, Aasmundstad TA, Handal M, Alkana RL, Morland J (1998)
Morphine-6-glucuronide-induced locomotor stimulation in mice: Role of opioid receptors
Pharmacol. Toxicol., 82 (1), 3-10
DOI 10.1111/j.1600-0773.1998.tb01390.x

Skurtveit S, Christophersen AS, Beylich KM, Bjorneboe A, Morland J (1998)
Study of rearrests for drunken driving in Norway
Forensic Sci.Int., 92 (1), 21-28
DOI 10.1016/S0379-0738(97)00199-0

Publications 1996

Christophersen AS, Beylich KM, Bjorneboe A, Skurtveit S, Morland J (1996)
Recidivism among drunken and drugged drivers in Norway
Alcohol Alcohol., 31 (6), 609-611

Publications 1995

Skurtveit S, Christophersen AS, Morland J (1995)
Female drivers suspected for drunken or drugged driving
Forensic Sci.Int., 75 (2-3), 139-148
DOI 10.1016/0379-0738(95)01785-2